EventsMOL2NET'15, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 1st ed.
Published
This submission belongs to the session 01. CHEMBIO.INFO-01: Cheminfo., Chemom., Comput. Quantum Chem. & Bioinfo. Congress, Cambridge, UK-Chapel Hill and Richmond, USA, 2015 of the event MOL2NET'15, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 1st ed.
Published date
04 Dec, 2015
Citation
Francisco J Romero Durán, Nerea Alonso, Olga Caamaño, Matilde Yañez, Xerardo Garcia-Mera, Multi-target Prediction of Neuroprotective Drugs, Synthesis, Assay, and Theoretical Study of Rasagiline Carbamates, in Proceedings of MOL2NET'15, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 1st ed., 5 December–15 December 2015, MDPI: Basel, Switzerland, doi: 10.3390/MOL2NET-1-b020
Share
Email
Facebook
Twitter
LinkedIn

Multi-target Prediction of Neuroprotective Drugs, Synthesis, Assay, and Theoretical Study of Rasagiline Carbamates

Francisco J Romero Durán 1
Nerea Alonso 2
Matilde Yañez 3
1. Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela (USC), Santiago de Compostela 15782, Spain; Clínica Zorrotzaurre, Bilbao 48014, Spain.
2. Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela (USC), Santiago de Compostela 15782, Spain
3. Department of Pharmacology, University of Santiago de Compostela (USC), Santiago de Compostela 15782
Abstract

Abstract: In this work, we developed a multi-target model for neuroprotective compounds reported in the CHEMBL database. The model predicted correctly >8300 experimental outcomes with Accuracy, Specificity, and Sensitivity above 80-90% in training and external validation series. This is model can different outcomes for >30 experimental measures in >400 different experimental protocols and related to >150 molecular and cellular targets present in 11 different organisms (including human). After that, we reported by the first time, the synthesis, characterization, and experimental assays of new series of chiral 1,2-rasagiline carbamate derivatives; not reported in previous works. This work is a synopsis of the results presented in our previous paper: Int J Mol Sci. 2014 Sep 24;15(9):17035-64. doi: 10.3390/ijms150917035.

Keywords
CHEMBL
Neuroprotective agents
Rasagiline derivatives
Asymmetric synthesis
Manuscript
Law, Software, & Cheminformatics: Copyright, Taxes, and Legal Issues
3D hierarchically scaffolds for bone repair: at the crossroads of experimental and computational outlooks